“…In accelerated aging, ROS production can no longer be controlled, and age-related diseases, such as cardiovascular diseases, metabolic disorders, cancer, and neurodegeneration, are the consequence [ 1 , 2 , 3 ]. Particularly in industrialized countries, health care has improved, and consequently life expectancy has increased [ 4 , 5 ]. Thus, the prevalence of age-related diseases is increasingly significant and has become a severe burden in terms of the quality of life of patients, health care, and socio-economic systems (as analyzed, e.g., by Bae et al for Korea [ 6 ]).…”